Skip to content
Screener

Medtronic MDT Q2 2026 earnings

Reported November 18, 2025 · Before market open

Revenue$9.0BBeat by $94.0M
EPS$1.36Beat by $0.05
Revenue estimate$8.9B
EPS estimate$1.31

Next report

Nov 17, 2026 (in a month)
Revenue estimate$9.5B
EPS estimate$1.34

Financials

Q2 2026

Income statement

See full
Revenue$9.0B+6.6%
Gross profit$5.9B+8.1%
Operating income$1.7B+5.7%
Net income$1.4B+8.2%
EPS (diluted)$1.07+8.1%

Balance sheet

See full
Cash & equivalents$1.3B-8.0%
Total debt$29.2B+2.7%
Total equity$48.7B+0.3%
Total assets$91.3B+1.4%

Cash flow

See full
Operating cash flow$925.0M-3.4%
CapEx$468.0M+15.8%
Free cash flow$457.0M-17.5%

Valuation & ratios

Valuation

as of 10/24/25
See full
Market cap$116.33B+0.8%
Enterprise value$144.21B+1.3%
P/E24.4×-2.5×
P/S3.3×-0.2×

Profitability

See full
Gross margin65.5%+0.5pp
Operating margin17.9%+1.5pp
Net margin13.7%+0.7pp
FCF margin15%-1.7pp

Returns & leverage

See full
Return on equity9.8%+1.2pp
Debt / equity0.6×0.0×
Current ratio2.4×+0.6×

Segments

By segment

See full
Cardiovascular$3.4B+10.8%
Neuroscience$2.6B+4.5%
Medical Surgical$2.2B+2.0%
Diabetes$757.0M+10.3%

FAQ

When did Medtronic report Q2 2026 earnings?
Medtronic (MDT) reported Q2 2026 earnings on November 18, 2025 before market open.
What were Medtronic's Q2 2026 revenue and EPS?
Medtronic reported revenue of $9.0B and eps of $1.36 for Q2 2026.
Did Medtronic beat estimates in Q2 2026?
Revenue beat the consensus estimate of $8.9B by $94.0M. EPS beat the consensus estimate of $1.31 by $0.05.
How did Medtronic's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.6% from $8.4B a year earlier and eps grew 7.9% from $1.26.
Where can I find Medtronic's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-25-052771) and the 10-Q periodic report (0001628280-25-053988) directly on SEC EDGAR. The filing index links above go to sec.gov.